Mini Review
Published on 24 Dec 2024
Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1504327
- 2,159 views
Type at least 3 characters
177 articles
articles
Case Report
Published on 17 Dec 2024
A patient with concurrent EBV-negative diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: a case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1463487
- 1,677 views
Case Report
Published on 12 Dec 2024
Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1508463
- 1,449 views
Case Report
Published on 09 Dec 2024
Case report: Vitamin B12 deficiency-associated hemolytic anemia
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1446241
- 8,403 views
- 3 citations
Study Protocol
Published on 06 Dec 2024
Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1436845
- 2,304 views
Original Research
Published on 05 Dec 2024
Prevalence of measurable residual disease in patients with refractory/relapsed multiple myeloma who reached complete response: a cross-sectional multicentric study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1480120
- 1,870 views
Review
Published on 03 Dec 2024
Delineation of erythropoietic intermediates by flow cytometry
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1496916
- 4,325 views
Original Research
Published on 02 Dec 2024
Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1472609
- 1,474 views
Original Research
Published on 26 Nov 2024
Exploring the regenerative capacity of the spleen following irradiation
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1396672
- 2,087 views
Original Research
Published on 22 Nov 2024
Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1492680
- 1,495 views
Case Report
Published on 15 Nov 2024
Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1435584
- 2,302 views
Case Report
Published on 13 Nov 2024
Case report: VEXAS syndrome and literature review
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1480436
- 2,407 views
- 2 citations
Review
Published on 29 Oct 2024
Early T-cell precursor acute lymphoblastic leukemia: diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1463410
- 9,340 views
- 2 citations
Editorial
Published on 18 Oct 2024
Editorial: Editors’ showcase: red cells, iron and erythropoiesis
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1457513
- 1,158 views
Perspective
Published on 18 Oct 2024
The CHIP-clinic as the catalyst of preventive medicine
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1459154
- 2,939 views
- 2 citations
Review
Published on 07 Oct 2024
Clonal evolution: a landmark of MPN evolution
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1473920
- 2,807 views
Review
Published on 27 Sep 2024
Recent advancements in gene therapy for sickle cell disease and β-thalassemia
in Gene Therapy, Cell Therapy and Hematology
Frontiers in Hematology
doi 10.3389/frhem.2024.1468952
- 18,899 views
- 9 citations
Review
Published on 25 Sep 2024
Dissecting dormancy and quiescence in hematopoietic stem cells
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1401713
- 4,219 views
- 3 citations
Original Research
Published on 11 Sep 2024
Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1438233
- 1,649 views
Editorial
Published on 29 Aug 2024
Editorial: Rising stars in hematopoiesis and stem cells 2023
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1477997
- 1,549 views
Perspective
Published on 27 Aug 2024
Sickle cell disease: a comparative perspective on global and national initiatives
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1457158
- 14,087 views
- 14 citations
Editorial
Published on 14 Aug 2024
Editorial: Glycobiology in hematology: a promising avenue for cancer diagnostics and therapeutics
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1465473
- 1,466 views
Review
Published on 09 Aug 2024
The nexus between Helicobacter pylori infection and anemia—a systematic review
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1423494
- 14,653 views
- 4 citations
Review
Published on 06 Aug 2024
Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1407698
- 5,312 views
- 6 citations